Jayne A. L. Houghton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jayne A. L. Houghton has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Tym Hattersley
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK
1 shared publication - Elisa De Franco
Clinical and Biomedical Sciences University of Exeter Exeter UK
1 shared publication - Evgenia Globa
Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv, Ukraine
1 shared publication - Kashyap Amratlal Patel
Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK
1 shared publication - Matthew Neil Wakeling
University of Exeter
1 shared publication - Nicola Jeffery
Department of Clinical and Biomedical Sciences, University of Exeter Faculty of Health and Life Sciences, Exeter, UK
1 shared publication
Latest Publications
- Open Access
- 14 November 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (6) , e004439
Widening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes
Introduction: Biallelic PDX1 variants are a rare cause of isolated pancreatic agenesis and neonatal diabetes (NDM) without exocrine pancreatic insufficiency, with 17 cases reported in the literature. Research design and methods: To determine the phenotypic variability caused by this rare genetic aetiology, we investigated 19 individuals with NDM resulting from biallelic disease-causing PDX1 variants. Results: Of the 19 individuals, 8 (42%) were confirmed to have exocrine insufficiency requiring replacement therapy. Twelve individuals (63.2%) had extrapancreatic features, including 8 (42%) with conditions affecting the duodenum and/or hepatobiliary tract. Defects in duodenum development are consistent with previous Pdx1 ablation studies in mice which showed abnormal rostral duodenum development. Conclusions: Our findings show that recessive PDX1 variants can cause a syndromic form of NDM, highlighting the need for clinical assessment of extrapancreatic features in individuals with NDM caused by PDX1 variants.
- 14 November 2024
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 12 (6) , e004439
Open AccessWidening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes
Introduction: Biallelic PDX1 variants are a rare cause of isolated pancreatic agenesis and neonatal diabetes (NDM) without exocrine pancreatic insufficiency, with 17 cases reported in the literature. Research design and methods: To determine the phenotypic variability caused by this rare genetic aetiology, we investigated 19 individuals with NDM resulting from biallelic disease-causing PDX1 variants. Results: Of the 19 individuals, 8 (42%) were confirmed to have exocrine insufficiency requiring replacement therapy. Twelve individuals (63.2%) had extrapancreatic features, including 8 (42%) with conditions affecting the duodenum and/or hepatobiliary tract. Defects in duodenum development are consistent with previous Pdx1 ablation studies in mice which showed abnormal rostral duodenum development. Conclusions: Our findings show that recessive PDX1 variants can cause a syndromic form of NDM, highlighting the need for clinical assessment of extrapancreatic features in individuals with NDM caused by PDX1 variants.
- 5 October 2019
- Published by Springer Nature
- Vol. 2076, 129-177
Diagnostic Genetic Testing for Monogenic Diabetes and Congenital Hyperinsulinemia
Monogenic diabetes and hyperinsulinism are genetically heterogeneous disorders. The determination of the genetic etiology defines the diagnostic subtype, predicts prognosis, and importantly can guide clinical management. This chapter focuses on the processes and methodologies utilized in the diagnostic testing for monogenic diabetes and congenital hyperinsulinism (i.e., Sanger sequencing and targeted next-generation sequencing).
- 5 October 2019
- Published by Springer Nature
- Vol. 2076, 129-177
Diagnostic Genetic Testing for Monogenic Diabetes and Congenital Hyperinsulinemia
Monogenic diabetes and hyperinsulinism are genetically heterogeneous disorders. The determination of the genetic etiology defines the diagnostic subtype, predicts prognosis, and importantly can guide clinical management. This chapter focuses on the processes and methodologies utilized in the diagnostic testing for monogenic diabetes and congenital hyperinsulinism (i.e., Sanger sequencing and targeted next-generation sequencing).